Novartis N
NOVN
CHF
STOCK MARKET:
SWX
Open
 
...
Large gap with delayed quotes
Last quote
01/17/2025 - 16:11:06
Bid
01/17/2025 - 16:11:06
Bid
Volume
Ask
01/17/2025 - 16:11:07
Ask
Volume
89.68
-0.91 ( -1.00% )
89.68
1,536
89.70
1,100
More information
Analysis by TheScreener
14.01.2025
Evaluation Neutral  
Interest Strong  
Sensibility Middle  
Analysis date: 14.01.2025
Global Evaluation
  Neutral
The stock is classified in the neutral zone since 13.09.2024.
Interest
  Strong
Strong interest since 07.01.2025.
Earnings Rev Trend
  Positive
 
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 29.10.2024 at a price of 95.74.
Evaluation
  Strongly undervalued
 
Based on its growth potential and our own criteria, at its current price the stock is strongly undervalued.
MT Tech Trend
  Neutral
 
The stock is currently trading close to its forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this (since 29.10.2024), the stock traded below its moving average. The confirmed Technical Reverse (Tech Reverse + 1.75%) point is .
4wk Rel Perf
  3.86%
 
The four week relative overperformance versus STOXX600 is 3.86%.
Sensibility
  Middle
The stock has been on the moderate-sensitivity level since 15.03.2024.
Bear Market Factor
  Middle
On average, the stock is likely to decline with the index.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 1.62%.
Mkt Cap in $bn
  196.10
With a market capitalization >$8bn, NOVARTIS AG is considered a large-cap stock.
G/PE Ratio
  1.10
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of .
LT P/E
  11.54
The estimated PE is for the year 2026.
LT Growth
  8.66%
The annualized growth estimate is for the current year to 2026.
Avg. Nb analysts
  21
Over the last seven weeks, an average of 21 analysts provided earnings per share estimates.
Dividend Yield
  3.99%
The twelve month estimated dividend yield represents 46.05% of earnings forecasts.
Beta
  81
For 1% of index variation, the stock varies on average by 0.81%.
Correlation
  0.52
51.84% of stock movements are explained by index variations.
Value at Risk
  10.82
The value at risk is estimated at CHF 10.82. The risk is therefore 12.01%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  02.01.2002